Skip to main content
. 2022 Oct 13;8(5):2588–2603. doi: 10.3390/tomography8050216

Table 3.

Radiological findings in the COVID-19 survivors who underwent CT examination at three and 12 months after discharge and showed persistent chest CT abnormalities. Subclassification in improved/stably abnormal/worsened (group 3/4/5) is not considered in this summary.

3-Month FU 12-Month FU p
No. of abnormal chest CT scans 49/63 (78%) 48/63 (76%) * 1.000
% of compromised lung volume 14.4 [10.6–21.2] 12.3 [9.2–15.9] <0.001
Type of CT pattern 0.038
GGO 8 (16) 2 (4)
Reticular 31 (63) 38 (79)
Combined 10 (21) 8 (17)
Consolidation 2 (4) 2 (4) 1.000
Architectural distortion 45 (92) 46 (96) 1.000
Bronchial dilatation 44 (90) 42 (88) 0.683
Emphysema 7 (14) 9 (19) 0.617
Cavitation 1 (2) 0 (0) NA **
Pleural effusion 1 (2) 1 (2) 1.000
Distribution
Bilateral 47 (96) 48 (100) NA **
Axial distribution (central/peripheral/neither) 1 (2)/18 (37)/30 (61) 0 (0)/28 (58)/20 (42) NA **
Cranio-caudal distribution (superior/medium/inferior/none) 2 (4)/1 (2)/7 (14)/39 (80) 1 (2)/6 (13)/12 (25)/29 (60) 0.047
RUL 48 (98) 45 (94) 0.479
ML 46 (94) 45 (94) 1.000
RLL 46 (94) 46 (96) 1.000
LUL 43 (88) 40 (83) 0.617
Lingula 44 (90) 43 (90) 1.000
LLL 46 (94) 47 (98) 0.480

Data are reported as median [IQR] (continuous/numerical variables) or number (%) (binary/categorical variables). p-values were computed by paired t-test (continuous variables with normal distribution), paired Mann–Whitney test (continuous variables with non-normal distribution), McNemar Chi-squared test (binary variables), or Marginal homogeneity test (categorical variables). * Among 49 patients with CT abnormalities at three months, only one case became normal at 12 months reassessment. ** p-values could not be computed due to the different number of levels. Abbreviations: GGO = ground-glass opacity, RUL = right upper lobe, ML = middle lobe, RLL = right lower lobe, LUL = left upper lobe, LLL = left lower lobe.